The MIOLive 2026 Congress aims to serve as a leading platform dedicated to advancing the practical and multidisciplinary management of interventional oncology (IO) within the Mediterranean region and internationally. Given the rapid technological and therapeutic developments in the field, the congress emphasizes a comprehensive approach that combines cutting-edge research, innovative techniques, and collaborative decision-making to improve patient outcomes.

The event is designed to bring together top experts, clinicians, surgeons, radiologists, and researchers to facilitate the exchange of knowledge, share real-world experiences through live case demonstrations, and promote interactive discussions that translate scientific advances into clinical practice.

Main themes addressed at MIOLive 2026 include:

• Hepatocellular Carcinoma (HCC): Exploring curative and palliative treatment options, including the role of liver transplantation, surgical approaches, systemic therapies, and interventional locoregional procedures.
• Intrahepatic Cholangiocarcinoma (iCCC): Discussing recent advances in imaging, surgical options, systemic treatments, and minimally invasive ablative techniques.
• Artificial Intelligence and Big Data: Examining emerging applications of AI in diagnosis, treatment planning, and predictive modeling, with attention to trustworthiness, safety, ethics, and bias.
• Multidisciplinary Treatment Strategies: Facilitating interactive panels on decision-making processes involving surgeons, radiologists, oncologists, and hepatologists.
• Innovative Technologies and Procedures: Covering the latest in functional imaging, deep learning approaches, portal interventions, and hybrid imaging techniques.
• Research and Future Perspectives: Highlighting recent impactful publications, ongoing clinical trials, and future directions in IO.
• Ethical and Safety Considerations: Emphasizing responsible integration of new technologies and ensuring safe, patient-centered care.
• Live Cases: Discussing new devices and techniques, highllighting the role of locoregional treatments. Emphasizing tips and tricks and cutting-edge real-life solutions

By fostering collaboration and knowledge-sharing among regional and international experts, MIOLive 2026 aims to enhance practical skills, promote evidence-based practices, and shape the future landscape of interventional oncology. The congress ultimately strives to improve the effectiveness, safety, and personalization of treatments for patients with intrahepatic cancers and other related conditions